EAACI Congress 2024
BackOAS 8 - Innovations in Food Allergy Immunotherapy
Friday 31 May, 16:45 PM -
18:15 PM Valencia, Spain
Granada
Oral Abstract Sessions
16:45
Preliminary results of first-in-human dose escalation of VLP Peanut in healthy subjects
16:57
Effects of Synbiotics on Faecal Short-Chain Fatty Acids in Cow’s Milk-Allergic Infants Receiving Amino Acid–based Formula during Early Life: Results of a Randomized Controlled Trial (PRESTO Study)
17:09
Designing Modified Variants of Ara h 1 and Ara h 2 for Safe and Effective Immunotherapy
17:21
Modified Peanut Allergen mRNA Induces Cross-Blocking Antibodies that Protect Against Allergic Reactions in an in-vivo Allergy Model
17:33
Intestinal-restricted location of allergen-specific regulatory T cells is driven by oral consumption of the allergen in murine models
17:45
The natural history of egg allergy in the EAT and EAT-On cohort
17:57
Allergen metabolism by human oral bacteria alters its allergenicity
